Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining

<div>Survival assays of GC patients from TCGA datasets based on MATN3 mRNA expression (high versus low). (a) K-M curves for OS of 350 GC sufferers. (b) K-M curves for survival without development of 372 GC sufferers. (c) Survival-reliant ROC curves confirm the prognosis value of MATN3-based prognosis indexes.</div>

Disease Markers

fig2

Figure 2

Figure 2: Identification of MATN3 as a Novel Prognostic Biomarker for Gastric Cancer through Comprehensive TCGA and GEO Data Mining 